European Pharmaceutical Review

MARCH 12, 2024

Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. The post Data integrity considerations in Pharma and Life Sciences appeared first on European Pharmaceutical Review.

Government 90

Government Pharma Ethics Training 90

MedCity News

JUNE 20, 2022

In other drug decision news, the Rhythm Pharmaceuticals product Imcivree added the rare disease Bardet-Beidl syndrome as a new approved indication. AbbVie drug Skyrizi is now approved for Crohn’s disease, making it the first treatment for the disorder that addresses a particular protein associated with inflammation.

Pharmaceutical products 98

Pharmaceutical products FDA Pharmaceutical Biopharma 98

European Pharmaceutical Review

MAY 17, 2023

A market report has shown that to improve efficiency, quality and to reduce costs in drug manufacturing , Pharma has been adopting automated quality management systems, digitalisation of processes and integration of data analytics. This helps pharma company’s sensitive data to be safe and secure. billion by 2031. billion in 2022.

Management 83

Management Marketing Manufacturing Pharmaceutical 83

World of DTC Marketing

MARCH 10, 2022

market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. AbbVie filed 55% of Imbruvica’s patent applications after FDA approval, the report said”.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Manufacturing 205

PM360

SEPTEMBER 7, 2023

Therapeutic Talk: Doctors’ Reactions to Recent FDA Approvals in Respiratory, Gastro, Infectious Disease, and More The number of times HCPs mentioned new products approved by the FDA over the course of the month of May. The most shared links by HCPs were for Arexvy , Rinvoq , and Inpefa.

Healthcare 52

Healthcare Healthcare FDA Doctors 52

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. How can these issues be addressed?

Pharmaceutical 95

Pharmaceutical Food and Drug Administration Transportation Manufacturing 95

Contrarian Sales Techniques

FEBRUARY 25, 2023

The results of these studies are carefully analyzed and scrutinized by regulatory bodies, such as the FDA in the United States. In Malaysia, the National Pharmaceutical Regulatory Agency (NPRA) regulates and ensures the safety, efficacy, and quality of pharmaceutical products on the market.

Side effects 52

Side effects Medical sales reps Insurance Pharmacology 52

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. Regulatory body – NMPA : all pharmaceutical products sold in the Chinese market need to be granted market authorization by NMPA.

Marketing 105

Marketing Insurance Medical Manufacturing 105

pharmaphorum

JULY 27, 2022

The paper, by a team from Imperial College London, concluded that the FDA gave the go ahead to 95% of the 89 products approved between 2010 and 2019 before EMA, with the Europeans trailing the Americans by a median of 241 days. Between 2012 and 2020, it averaged 3% each year, whereas Spain’s share, for example, had increased from 2.6%

Government 87

Government Recruitment Medicine Competition 87

Pharmaceutical Technology

MARCH 22, 2023

He adds that in the early 2000s there were no set standards for RFID in the pharma industry, so the compatibility between systems was not guaranteed. The US Food and Drug Administration (FDA) has provided guidance for the use of RFID in the drug supply chain and to standardise the data format.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma FDA 105

European Pharmaceutical Review

DECEMBER 27, 2023

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. Approved cellular and gene therapy products [Internet]. FDA; 2022 [cited 2023 Mar]. 6-8 Clinical recommendations also change. 2021;3(S1):6–10.

Manufacturing 85

Manufacturing Food and Drug Administration Patients Pharma 85

Cadensee

JULY 20, 2021

So, do you listen to them at the point when a pharma company decides what drug it needs to make? So, you see on one side, there's a special body of the FDA trying to listen to patients to find new targets for health and for pharmaceutical technology. I would say pharmaceutical industry is usually much more cautious.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. Pharma 4.0. In the fast-approaching era of Pharma 4.0,

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical products Manufacturing Pharmaceutical 52

Pharmaceutical Technology

APRIL 26, 2023

The choice of the primary packaging material for pharmaceuticals is influenced by factors such as the product’s physicochemical properties, stability, route of administration, and regulatory requirements.

Manufacturing 52

Manufacturing Medical Food and Drug Administration Pharmaceutical 52

Pharmaceutical Technology

MARCH 2, 2023

On 1 March, the FDA issued the International Council for Harmonisation (ICH) final guidance on the use of continuous manufacturing in drug production. This publication marks the FDA’s proactive steps to ease the pharmaceutical’s industry transition to these advanced processes, states the announcement.

Manufacturing 84

Manufacturing Pharma FDA Pharmaceutical products 84